Opportunities in viral vector manufacturing arise from rising demand for GMP-grade materials and increasing gene therapy ...

About OXB OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life ...

Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on surgery, chemotherapy, or radiotherapy. Among RNA-based ...

Oxford BioMedica ( ($GB:OXB) ) has shared an announcement. Oxford Biomedica (OXB) has been recognized as a Champion in the ‘Cell & Gene Therapy’ ...

OXB to participate in upcoming investor conferences and events Oxford, UK – 27 October 2025: OXB (LSE: OXB), a global quality and innovation-led ...